The rise of Viagra initially drove a period of growth for pharma, but recent changes present a uncertain picture for those considering a stake. Generic versions are eating into revenue, and persistent patent challenges https://ellathpx729511.ja-blog.com/41480836/the-blue-pill-and-the-pharmaceutical-industry-a-precarious-play